Protocol Ledger

NCT05480306 · Phase II · COMPLETED

Phase 2 Study of DKN-01 in Colorectal Cancer

Interventional Phase II clinical trial protocol NCT05480306 sponsored by Leap Therapeutics in Oncology and Hematology, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2022-08-30 Enrollment: 188 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT05480306
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)188 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)2 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT05480306
Protocol FieldVerified Registry Value
NCT IdentifierNCT05480306
Consolidated Lead SponsorLeap Therapeutics
Therapeutic Condition CohortOncology and Hematology
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment188 participants (ACTUAL)
Registered Start Date2022-08-30
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT05480306
Hospital Research SiteLocationSite Profile
UCLA Health and Jonsson Comprehensive Cancer CenterLos Angeles, CAOpen Hospital Dossier ->
Miami Cancer InstituteMiami, FLOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Oncology and Hematology Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI